carmustine has been researched along with Myocarditis in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fourteen patients with American Burkitt's lymphoma resistant to conventional chemotherapy were treated with high-dose combination chemotherapy and intensive supportive care." | 1.26 | Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse. ( Appelbaum, FR; Deisseroth, AB; Graw, RG; Herzig, GP; Levine, AS; Magrath, IT; Pizzo, PA; Poplack, DG; Ziegler, JL, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appelbaum, FR | 1 |
| Deisseroth, AB | 1 |
| Graw, RG | 1 |
| Herzig, GP | 1 |
| Levine, AS | 1 |
| Magrath, IT | 1 |
| Pizzo, PA | 1 |
| Poplack, DG | 1 |
| Ziegler, JL | 1 |
| Panella, TJ | 1 |
| Peters, W | 1 |
| White, JG | 1 |
| Hannun, YA | 1 |
| Greenberg, CS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors[NCT00001301] | 107 participants | Observational | 1992-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for carmustine and Myocarditis
| Article | Year |
|---|---|
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse.
Topics: Adolescent; Adult; Burkitt Lymphoma; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabi | 1978 |
Platelets acquire a secretion defect after high-dose chemotherapy.
Topics: Adenosine Triphosphate; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Platelet Disord | 1990 |